Diffusion of magnetic nanoparticles in a multi-site injection process within a biological tissue during magnetic fluid hyperthermia using lattice Boltzmann method

Golneshan, Ali Akbar; Lahonian, Mansour

doi:10.1016/j.mechrescom.2011.05.012

Cited by 44 publications

(20 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diffusion of MNPs inside the tissue was simulated by Golneshan and Lahonian (2011a). A square region with side of was chosen as the domain of the analysis (Figure 8).…”

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

“…Results show that the concentration of ferrofluid is maximum at the injection site, and decreases rapidly with increasing distance from it. Also, concentration of ferrofluid decreases at the injection area with time and increases in the surrounding of injection site [Golneshan and Lahonian (2011a)]. , and different infusion flow rates, just minutes after the end of ferrofluid injection.…”

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

“…, and different infusion flow rates, just minutes after the end of ferrofluid injection. Results show that the increasing infusion flow rate, increases concentration of ferrofluid in the vicinity of the injection site while decreasing the concentration in the layers far from the injection site [Golneshan and Lahonian (2011a)]. , and different infusion flow rates, just 20 minutes after the end of ferrofluid injection [Golneshan and Lahonian (2011a)].…”

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

“…Results show that the increasing infusion flow rate, increases concentration of ferrofluid in the vicinity of the injection site but decreases the concentration in the layers far from the injection site [Golneshan and Lahonian (2010), Golneshan and Lahonian (2011a)]. Golneshan and Lahonian (2011a) They considered multi-site injection as shown in Figure 13d and divided the irregular tumor almost into four equal sections. In each injection site, one fourth the amount of .…”

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

“…A successful MFH treatment is substantially dependent on the MNPs distribution in the tissue [Bagaria and Johnson (2005), Salloum et al (2008a), Salloum et al (2008b), Lin andLiu (2009), Bellizzi andBucci (2010), Golneshan and Lahonian (2011a)]. …”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Diffusion of Magnetic Nanoparticles Within a Biological Tissue During Magnetic Fluid Hyperthermia

Lahonian¹

2013

Hyperthermia

Self Cite

View full text Add to dashboard Cite

“…Diffusion of MNPs inside the tissue was simulated by Golneshan and Lahonian (2011a). A square region with side of was chosen as the domain of the analysis (Figure 8).…”

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

Section: Diffusion Of Mnps Within the Biological Tissuementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Diffusion of Magnetic Nanoparticles Within a Biological Tissue During Magnetic Fluid Hyperthermia

Lahonian¹

2013

Hyperthermia

Self Cite

View full text Add to dashboard Cite

Magnetic Fluid Hyperthermia Based on Magnetic Nanoparticles: Physical Characteristics, Historical Perspective, Clinical Trials, Technological Challenges, and Recent Advances

Etemadi

Plieger

2020

Advanced Therapeutics

View full text Add to dashboard Cite

Advances in nanotechnology have resulted in the introduction of magnetic fluid hyperthermia (MFH), a promising noninvasive therapeutic localized cancer treatment. Exposure of a fluid of superparamagnetic iron oxide nanoparticles (IONPs) to an alternating magnetic field (AMF) operating at biologically benign conditions leads to heat dissipation within the tumor and ultimate apoptosis and/or necrosis. Despite use in a clinical setting, there are still impediments preventing widespread use of MFH. These include insufficient heat dissipation potency of IONP fluid, inadequate dose or concentration of deposited fluid to the tumor, inhomogeneous distribution of fluid inside the tumor, the lack of control of real‐time monitoring of temperature rises during treatment, and exposure of the patients to X‐ray radiation produced by computed tomography (CT) scans. Accordingly, massive efforts have been put forth to promote the successful clinical adoption of MFH. In this contribution, the technique of MFH is described, including the present state of clinical MFH. The physical mechanisms behind heat dissipation by magnetic nanoparticles (MNPs) that instigate cell death pathways are discussed, as is recent technological progress in the field toward the advancement of MFH. Finally, an outlook on the future considerations required to accelerate the clinical adoption of MFH is presented.

show abstract

Magnetic Nanoparticle Hyperthermia

Bellizzi¹,

Bucci

2018

Emerging Electromagnetic Technologies for Brain Diseases Diagnostics, Monitoring and Therapy

View full text Add to dashboard Cite

Diffusion of magnetic nanoparticles in a multi-site injection process within a biological tissue during magnetic fluid hyperthermia using lattice Boltzmann method

Cited by 44 publications

References 22 publications

Diffusion of Magnetic Nanoparticles Within a Biological Tissue During Magnetic Fluid Hyperthermia

Diffusion of Magnetic Nanoparticles Within a Biological Tissue During Magnetic Fluid Hyperthermia

Magnetic Fluid Hyperthermia Based on Magnetic Nanoparticles: Physical Characteristics, Historical Perspective, Clinical Trials, Technological Challenges, and Recent Advances

Magnetic Nanoparticle Hyperthermia

Contact Info

Product

Resources

About